Related Experiment Video
Updated: Sep 2, 2025

An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides
Published on: November 29, 2016
SOX2 and PRAME in the "reprogramming" of seminoma cells
Agnese Orsatti1, Maria Sirolli1, Francesca Ambrosi2
1Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Background:
In recent years, several studies investigated the complex process called "reprogramming" of seminoma (S) cells. The accepted pathogenetic model is a complex network including SOX2, SOX17, OCT3/4 and PRAME, which modulates the epigenetic transcription of numerous downstream genes and drives a divergent gene expression profile resulting in the transition from pure S (P-S) to S component (S-C) of mixed germ cell tumors of the testis (M-GCTT), and finally to embryonal carcinoma (EC). Herein, we tested a large cohort of GCTT with SOX2 and PRAME to evaluate their expression in the evolutionary steps of GCTT and verify if the modulation in the expression of these two molecules could be relevant for the fate of GCTT.
Methods:
We tested 43, 19 and 17 consecutive and retrospectively enrolled cases of GCTT, germ cell neoplasia in situ (GCNIS) and uninvolved background testes (UBT), respectively. SOX2 and PRAME expressions have been evaluated with H-score and compared by adopting the appropriate statistic tests (Student's t-test and Mann-Whitney U test).
Results:
We found that SOX2 was more expressed by nonseminomatous-GCTT (NS-GCTT) (p < 0.001) and EC (p < 0.001) rather than S; by contrast, PRAME showed an opposite expression profile being expressed by S but not by NS-GCTT (p < 0.001) and EC (p < 0.001). S-C showed different expressions of SOX2 and PRAME compared to both P-S (p = 0.002 and <0.001, respectively) and EC (p < 0.001 and 0.042, respectively), with intermediate values between these latter two categories. GCNIS and UBT showed no expression of SOX2 (scattered positive Leydig cells) but high H-score levels of PRAME.
Conclusions:
SOX2 and PRAME are differentially expressed and specularly modulated during the "reprogramming" of S cells [P-S (high levels of PRAME, no expression/low levels of SOX2) → S-C (intermediate levels of PRAME, intermediate levels of SOX2) → EC (no expression/low levels of PRAME, high levels of SOX2)], therefore supporting a complex pathogenetic model where the interactions between these two molecules are crucial in determining the fate of GCTT.
Insights
SOX2 and PRAME expression levels change during germ cell tumor progression. High PRAME and low SOX2 indicate early stages, while high SOX2 and low PRAME suggest advanced tumors like embryonal carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Seminoma (S) cell reprogramming involves SOX2, SOX17, OCT3/4, and PRAME.
- This network influences gene expression, driving transitions from pure S (P-S) to S component (S-C) in mixed germ cell tumors of the testis (M-GCTT), and finally to embryonal carcinoma (EC).
Purpose of the Study:
- To evaluate SOX2 and PRAME expression in germ cell tumors of the testis (GCTT).
- To determine if SOX2 and PRAME modulation is relevant to GCTT evolution and fate.
Main Methods:
- Tested 43 GCTT, 19 GCNIS, and 17 UBT cases.
- Assessed SOX2 and PRAME expression using H-score.
- Employed Student's t-test and Mann-Whitney U test for statistical comparison.
Main Results:
- SOX2 expression was higher in nonseminomatous-GCTT (NS-GCTT) and EC than in S (p < 0.001).
- PRAME expression was higher in S than in NS-GCTT and EC (p < 0.001).
- S-C showed intermediate SOX2 and PRAME levels compared to P-S and EC.
Conclusions:
- SOX2 and PRAME exhibit differential and opposing expression patterns during S cell reprogramming.
- These molecules are crucial in determining GCTT fate, supporting a complex pathogenetic model.
Related Concept Videos
Methods of Nuclear Reprogramming
Somatic to iPS Cell Reprogramming
Pleiotropy
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Spermatogenesis
Introduction to Nuclear Reprogramming

